Charles A. McWherter Ph.D.
Net Worth

Last updated:

What is Charles A. McWherter Ph.D. net worth?

The estimated net worth of Dr. Charles A. McWherter Ph.D. is at least $8,133,582 as of 19 Jan 2024. He has earned $2,154,682 from insider trading and has received compensation worth at least $5,978,900 in CymaBay Therapeutics, Inc..

What is the salary of Charles A. McWherter Ph.D.?

Dr. Charles A. McWherter Ph.D. salary is $597,890 per year as Chief Scientific Officer in CymaBay Therapeutics, Inc..

How old is Charles A. McWherter Ph.D.?

Dr. Charles A. McWherter Ph.D. is 70 years old, born in 1955.

What stocks does Charles A. McWherter Ph.D. currently own?

As insider, Dr. Charles A. McWherter Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
CymaBay Therapeutics, Inc. (CBAY) Chief Scientific Officer 15,000 $0 $0

What does CymaBay Therapeutics, Inc. do?

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.

CBAY logo
CBAY
CymaBay Therapeutics, Inc.

Charles A. McWherter Ph.D. insider trading

CymaBay Therapeutics, Inc.

Dr. Charles A. McWherter Ph.D. has made 9 insider trades between 2015-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 21,749 units of CBAY stock on 18 May 2023. As of 19 Jan 2024 he still owns at least 15,000 units of CBAY stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 1,916 $1.82 $3,487
Option
Employee Stock Option (right to buy) 3,125 $11.69 $36,531
Option
Employee Stock Option (right to buy) 2,778 $1.72 $4,778
Option
Employee Stock Option (right to buy) 8,334 $10 $83,340
Option
Employee Stock Option (right to buy) 1,916 $1.82 $3,487
Option
Employee Stock Option (right to buy) 2,250 $1.06 $2,385
Sale
Common Stock 7,291 $23.67 $172,585
Option
Common Stock 8,334 $10 $83,340
Option
Common Stock 2,778 $1.72 $4,778
Option
Common Stock 3,125 $11.69 $36,531
Option
Common Stock 2,250 $1.06 $2,385
Option
Employee Stock Option (right to buy) 6,504 $5 $32,520
Option
Common Stock 4,828 $5 $24,140
Sale
Common Stock 11,332 $21.48 $243,445
Option
Common Stock 6,504 $5 $32,520
Option
Employee Stock Option (right to buy) 3,892 $5 $19,460
Option
Common Stock 11,342 $5 $56,710
Sale
Common Stock 11,342 $18.28 $207,298
Option
Employee Stock Option (right to buy) 236 $5 $1,180
Option
Employee Stock Option (right to buy) 6,506 $5 $32,530
Option
Employee Stock Option (right to buy) 708 $5 $3,540
Option
Employee Stock Option (right to buy) 6,506 $5 $32,530
Option
Employee Stock Option (right to buy) 236 $5 $1,180
Option
Employee Stock Option (right to buy) 3,892 $5 $19,460
Sale
Common Stock 21,743 $14.07 $305,946
Option
Employee Stock Option (right to buy) 708 $5 $3,540
Option
Common Stock 21,743 $5 $108,715
Option
Employee Stock Option (right to buy) 10,401 $5 $52,005
Option
Common Stock 21,746 $5 $108,730
Option
Employee Stock Option (right to buy) 236 $5 $1,180
Option
Employee Stock Option (right to buy) 708 $5 $3,540
Option
Employee Stock Option (right to buy) 10,404 $5 $52,020
Option
Employee Stock Option (right to buy) 3,892 $5 $19,460
Option
Employee Stock Option (right to buy) 6,506 $5 $32,530
Sale
Common Stock 21,746 $16.22 $352,742
Sale
Common Stock 21,746 $11.47 $249,361
Option
Employee Stock Option (right to buy) 10,404 $5 $52,020
Option
Employee Stock Option (right to buy) 708 $5 $3,540
Option
Common Stock 21,746 $5 $108,730
Option
Employee Stock Option (right to buy) 6,506 $5 $32,530
Option
Employee Stock Option (right to buy) 3,892 $5 $19,460
Option
Employee Stock Option (right to buy) 236 $5 $1,180
Option
Employee Stock Option (right to buy) 236 $5 $1,180
Sale
Common Stock 21,749 $11.43 $248,526
Option
Employee Stock Option (right to buy) 6,506 $5 $32,530
Option
Employee Stock Option (right to buy) 708 $5 $3,540
Option
Common Stock 21,749 $5 $108,745
Option
Employee Stock Option (right to buy) 10,407 $5 $52,035
Option
Employee Stock Option (right to buy) 3,892 $5 $19,460
Option
Employee Stock Option (right to buy) 708 $5 $3,540
Option
Common Stock 21,749 $5 $108,745
Option
Employee Stock Option (right to buy) 6,506 $5 $32,530
Option
Employee Stock Option (right to buy) 10,407 $5 $52,035
Option
Employee Stock Option (right to buy) 3,892 $5 $19,460
Sale
Common Stock 21,749 $8.16 $177,385
Option
Employee Stock Option (right to buy) 236 $5 $1,180
Option
Employee Stock Option (right to buy) 236 $5 $1,180
Option
Employee Stock Option (right to buy) 3,892 $5 $19,460
Sale
Common Stock 21,749 $9.08 $197,394
Option
Common Stock 21,749 $5 $108,745
Option
Employee Stock Option (right to buy) 10,407 $5 $52,035
Option
Employee Stock Option (right to buy) 708 $5 $3,540
Option
Employee Stock Option (right to buy) 6,506 $5 $32,530
Purchase
Common Stock 5,000 $8.67 $43,345
Purchase
Common Stock 5,000 $7.43 $37,130
Purchase
Common Stock 3,000 $1.68 $5,040
Purchase
Common Stock 2,000 $3.16 $6,314

CymaBay Therapeutics key executives

CymaBay Therapeutics, Inc. executives and other stock owners filed with the SEC: